<DOC>
	<DOCNO>NCT00050206</DOCNO>
	<brief_summary>The purpose study determine efficacy ( well drug work ) , safety , side effect olanzapine compare placebo treatment mania bipolar disorder adolescent . Both potential benefit side effect olanzapine evaluate throughout trial .</brief_summary>
	<brief_title>Olanzapine Versus Placebo Treatment Mania Adolescents With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male female patient , 13 17 year age must yet reach 18th birthday prior Visit 1 , inform consent obtain . Patients must diagnosis bipolar I disorder currently display acute mania mixed episode . Both patient patient 's parent/authorized legal representative must understand nature study must sign document grant consent . Female patient childbearing potential must test negative pregnancy time enrollment base serum pregnancy test . Female patient either pregnant nursing . Current diagnosis schizophrenia , schizophreniform disorder , schizoaffective disorder . Patient acute unstable medical condition , intensive care unit hospitalization disease anticipate within 6 month . Patients previously respond adequate dose and/or duration olanzapine treatment . Patients judge clinically serious suicidal risk .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>